Browsing by Author LUK JOHN MOONCHING

Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)
17-May-2017Biotransformation of volatiles in fermented osmanthus (Osmanthus fragrans) flowers by yeastYC Xiong; J Luk ; MW Cheong; Philip Curran; S.-Q. Liu ; KH Ng; B Yu
2011Interleukin 17a promotes hepatocellular carcinoma metastasis via NF-kB induced matrix metalloproteinases 2 and 9 expressionLi J.; Lau G.K.-K.; Chen L. ; Dong S.-s.; Lan H.-Y.; Huang X.-R.; Li Y.; Luk J.M. ; Yuan Y.-F.; Guan X.-y.
5-Apr-2010Proteomics of hepatocellular carcinoma: Serum vimentin as a surrogate marker for small tumors (≤2 cm)Sun, S.; Poon, R.T.P.; Lee, N.P.; Yeung, C.; Chan, K.L.; Ng, I.O.L.; Day, P.J.R.; Luk, J.M. 
Dec-2010Role of cadherin-17 in oncogenesis and potential therapeutic implications in hepatocellular carcinomaLee, N.P.; Poon, R.T.P.; Shek, F.H.; Ng, I.O.L.; Luk, J.M. 
2009Role of LPS/CD14/TLR4-mediated inflammation in necrotizing enterocolitis: Pathogenesis and therapeutic implicationsChan, K.L.; Wong, K.F.; Luk, J.M. 
Jan-2011Serum soluble E-cadherin is a potential prognostic marker in esophageal squamous cell carcinomaChung, Y.; Law, S.; Kwong, D.L.W.; Luk, J.M. 
Jan-2010Targeting cadherin-17 inactivates wnt signaling and inhibits tumor growth in liver carcinoma (Hepatology (2009) 50, DOI: 10.1002/hep.23143)Luk, J.M. 
Mar-2012Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agentsWong, K.-F. ; Yuan, Y.; Luk, J.M.